Todd M. Everson

Todd M. Everson

Auto-generated profile, based on publicly available information

Todd M. Everson

Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TETodd M. Everson
Todd M. Everson
MVMarta Vives-Usano
Marta Vives-Usano
ESEmie Seyve
Emie Seyve
ACAndres Cardenas
Andres Cardenas
MLMarina Lacasaña
Marina Lacasaña
MBMariona Bustamante
Mariona Bustamante
Maternal smoking during pregnancy (MSDP) contributes to poor birth outcomes, in part through disrupted placental functions, which may be reflected in the placental epigenome. Here we present a meta-analysis of the associations between MSDP and placental DNA methylation (DNAm) and between DNAm and birth outcomes within the Pregnancy And Childhood Epigenetics (PACE) consortium (N = 1700, 344 with MSDP). We identify 443 CpGs that are associated with MSDP, of which 142 associated with birth outcomes, 40 associated with gene expression, and 13 CpGs are associated with all three. Only two CpGs have consistent associations from a prior meta-analysis of cord blood DNAm, demonstrating substantial tissue-specific responses to MSDP. The placental MSDP-associated CpGs are enriched for environmental response genes, growth-factor signaling, and inflammation, which play important roles in placental function. We demonstrate links between placental DNAm, MSDP and poor birth outcomes, which may better inform the mechanisms through which MSDP impacts placental function and fetal growth.

16 January 2018 in Environmental Health Perspectives
Verified
Journal Article
Open access
TETodd M. Everson
Todd M. Everson
TPTracy Punshon
Tracy Punshon
BJBrian P. Jackson
Brian P. Jackson
KHKe Hao
Ke Hao
LLLambertini Luca
Lambertini Luca
CMCarmen J. Marsit
Carmen J. Marsit
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences


21 August 2015 in Genome Medicine
Verified
Journal Article
Open access
PDF file
TETodd M. Everson
Todd M. Everson
GLGenevieve Lyons
Genevieve Lyons
HZHongmei Zhang
Hongmei Zhang
NSNelís Soto-Ramírez
Nelís Soto-Ramírez
GLGabrielle A. Lockett
Gabrielle A. Lockett
WKWilfried Karmaus
Wilfried Karmaus
The prevalence of allergic diseases are increasing worldwide, emphasizing the need to elucidate their pathogeneses. The aims of this study were to use a two-stage design to identify DNA methylation levels at cytosine–phosphate–guanine (CpG) sites across the genome associated with atopy and high serum immunoglobulin E (IgE), then to replicate our findings in an independent cohort. Atopy was assessed via skin prick tests and high serum IgE. Methylation levels were measured from whole blood using the Illumina Infinium HumanMethylation450 BeadChip from 18-year-old women (n = 245) and men (n = 122) in the Isle of Wight birth cohort. After data cleaning and processing, and removing probes with possible single nucleotide polymorphisms, DNA methylation levels from 254,460 CpG sites from the 245 women were subjected to recursive Random Forest feature selection for stage 1. The sites selected from stage 1 were tested in stage 2 for associations with atopy and high IgE levels (>200 kU/L) via logistic regression adjusted for predicted cell-type proportions and sex. Sites significantly associated with atopy in stage 2 underwent replication tests in the independent Swedish birth cohort BAMSE (n = 464). In stage 1, 62 sites were selected, of which 22 were associated with atopy in stage 2 (P-value range 6.5E−9 to 1.4E−5) and 12 associated with high IgE levels (P-value range 1.1E−5 to 7.1E−4) at the Bonferroni adjusted alpha (0.05/62 = 0.0008). Of the 19 available sites, 13 were replicated. We identified 13 novel epigenetic loci associated with atopy and high IgE that could serve as candidate loci for future studies; four were within genes with known roles in the immune response (cg04983687 in the body of ZFPM1, cg18219873 in the 5′UTR of PRG2, cg27469152 in the 3′UTR of EPX, and cg09332506 in the body of COPA).

12 March 2016 in Allergy
Verified
Journal Article
Closed access
PDF file
GLG. A. Lockett
G. A. Lockett
NSN. Soto‐Ramírez
N. Soto‐Ramírez
MRM. A. Ray
M. A. Ray
TET. M. Everson
T. M. Everson
CXC.‐J. Xu
C.‐J. Xu
John HollowayJohn Holloway
John Holloway

30 May 2017 in Environmental Health
Verified
Journal Article
Open access
PDF file
Akhilesh KaushalAkhilesh Kaushal
Akhilesh Kaushal
HZHongmei Zhang
Hongmei Zhang
WKWilfried Karmaus
Wilfried Karmaus
TETodd M. Everson
Todd M. Everson
CMCarmen J. Marsit
Carmen J. Marsit
Shu-Li WangShu-Li Wang
Shu-Li Wang
In utero arsenic exposure may alter fetal developmental programming by altering DNA methylation, which may result in a higher risk of disease in later life. We evaluated the association between in utero arsenic exposure and DNA methylation (DNAm) in cord blood and its influence in later life. Genome-wide DNA methylation in cord blood from 64 subjects in the Taiwanese maternal infant and birth cohort was analyzed. Robust regressions were applied to assess the association of DNA methylation with in utero arsenic exposure. Multiple testing was adjusted by controlling false discovery rate (FDR) of 0.05. The DAVID bioinformatics tool was implemented for functional annotation analyses on the detected CpGs. The identified CpGs were further tested in an independent cohort. For the CpGs replicated in the independent cohort, linear mixed models were applied to assess the association of DNA methylation with low-density lipoprotein (LDL) at different ages (2, 5, 8, 11 and 14 years). In total, 579 out of 385,183 CpGs were identified after adjusting for multiple testing (FDR = 0.05), of which ~60% were positively associated with arsenic exposure. Functional annotation analysis on these CpGs detected 17 KEGG pathways (FDR = 0.05) including pathways for cardiovascular diseases (CVD) and diabetes mellitus. In the independent cohort, about 46% (252 out of 553 CpGs) of the identified CpGs showed associations consistent with those in the study cohort. In total, 11 CpGs replicated in the independent cohort were in the pathways related to CVD and diabetes mellitus. Via longitudinal analyses, we found at 5 out of the 11 CpGs methylation was associated with LDL over time and interactions between DNA methylation and time were observed at 4 of the 5 CpGs, cg25189764 (coeff = 0.157, p-value = 0.047), cg04986899 (coeff. For interaction [coeff.int] = 0.030, p-value = 0.024), cg04903360 (coeff.int = 0.026, p-value = 0.032), cg08198265 (coeff.int = −0.063, p-value = 0.0021), cg10473311 (coeff.int = −0.021, p-value = 0.027). In utero arsenic exposure was associated with cord blood DNA methylation at various CpGs. The identified CpGs may help determine pathological epigenetic mechanisms linked to in utero arsenic exposure. Five CpGs (cg25189764, cg04986899, cg04903360, cg08198265 and cg10473311) may serve as epigenetic markers for changes in LDL later in life.